Frazier Life Sciences Management L.P. lifted its stake in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) by 0.4% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 6,495,392 shares of the company’s stock after buying an additional 25,000 shares during the quarter. Mirum Pharmaceuticals makes up about 10.3% of Frazier Life Sciences Management L.P.’s […]
Brokerages Set Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Target Price at $54.13 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) – Stock analysts at HC Wainwright lifted their FY2025 earnings per share (EPS) estimates for shares of Mirum Pharmaceuticals in a research note issued on Tuesday, January 9th. HC Wainwright analyst E. Arce now expects that the company will post earnings per share of $3.37 for the year, […]
JPMorgan Chase & Co. restated their overweight rating on shares of Mirum Pharmaceuticals (NASDAQ:MIRM – Free Report) in a research report sent to investors on Monday morning, Benzinga reports. The firm currently has a $37.00 target price on the stock. A number of other analysts also recently weighed in on the company. Evercore ISI restated […]
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Given Consensus Rating of "Buy" by Brokerages theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.